Steve Rosenberg has been a life science and healthcare executive for 40+ years and is currently CEO of uMotif. He commercialized the first integrated clinical technology suite at Phase Forward/Oracle. Top pharma and biotech executives depend on him for blunt and incisive advice â about the industry’s failure to engage patients and what we need to do to better understand what patients need.
He also believes that when those in pharma and biotech talk about diversity, the sponsors don’t think about the need for different approaches for different patient populations, other than their geography. Outsourcing Pharma caught up with him for a pre-SCOPE chat to find out what uMotif would be bringing to the summit and the messages he has for those in the industry.
